Principal Scientist, CRCHUM
Associate Professor, Department of Psychiatry, Université de Montréal
Interim Chief, Department of Psychiatry, CHUM
Psychiatrist, Addiction Psychiatry Unit, CHUM
For questions related to Clinic and Department of Psychiatry:
Céline Carrier, 514 890-8000, ext. 13109
For questions related to research activities:
Amel Zertal, 514 890-8000, ext. 36153
For media requests:
Addiction Psychiatry, addiction, psychiatric comorbidity, drug craving, endocannabinoid system, clinical trials, translational research, hepatitis C, access to medical and psychiatric care by substance abusers.
Development and study of innovative treatment for addiction and psychiatric comorbidity. Neurobiological studies to explore the role of the endocannabinoid system in addiction and drug-seeking behaviours. Clinical trials and translational research to assess the modulation of the endocannabinoid system as a strategy to treat substance dependence.
Studies of intermediate phenotypes linking genetic and neurobiological factors to addiction. Development of innovative interventions to facilitate access to health care, notably for hepatitis C, among substance abuse patients.
President, Centre d'expertise et de collaboration en troubles concomitants du RUIS, Université de Montréal
Adjunct assistant Clinical professor, Department of Psychiatry, Mount Sinai School of Medicine (New York)